Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized Controlled Clinical Trial Evaluating the Effect of Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

NCT03398538 is registered in ClinicalTrials.gov with ETS Wound Care, LLC as lead sponsor.

NCT NCT03398538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03398538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized Controlled Clinical Trial Evaluating the Effect of Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
Lead sponsor
ETS Wound Care, LLC
Phase
Not applicable
Overall status
Completed
Start date
December 26, 2017
Completion date
October 31, 2018
Enrollment
40 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot, diabetic foot ulcer, ulcer foot